According to a recent Innovative Medicines Canada report, growth in chronic diseases and increased drug claims are two key factors increasing the cost of drug claims. What disparities need to be addressed in order to ensure medicines are accessible to all Canadians? To help us with the discussion is Pamela Fralick. Pamela is the President and CEO of Innovative Medicines Canada.
Pamela Fralick – National Pharmacare Has Its Flaws – PODCAST
Published
Share
